We would like to highlight Derma Sciences Inc. (OTCBB: DSCI). The company is a global manufacturer and marketer of advanced wound-care products. Its key product, MEDIHONEY, is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor of the patented honey-based technology -- and is the leading brand of honey-based dressings for the management of wounds and burns.
In the company’s news yesterday,
Derma Sciences Inc. (OTCBB: DSCI) announced it will commence the sale of its novel MOBILITY1 Intermittent Pneumatic Compression Therapy Device beginning in October. The commercial launch will allow the company to target the nearly 7 million people afflicted with chronic venous insufficiency.
Derma Sciences will launch MOBILITY 1 after introducing the product to vascular surgeons at the 9th Annual New Cardiovascular Horizons (NCVH) Conference, September 10-13, 2008, in New Orleans. MOBILITY 1 is used for the treatment of chronic venous insufficiency, venous leg ulcers, lymphadema, the prevention of deep vein thrombosis, and numerous other indications.
Derma Sciences CEO Ed Quilty said MOBILITY 1 is the only product of its kind to answer the unmet needs among mobile patients with unfavorable results as a result of traditional static compression products such as stockings and compression wraps.
“This is another significant milestone for Derma as we continue to launch novel and important new technologies into the advanced wound care market … Allowing these patients to continue on with their normal lifestyle, getting them back to work sooner than later, will be a significant advantage over other pneumatic devices,” Quilty stated in the press release.
“This should help drive efficacy, and potentially reduce the number of active leg ulcers and complications associated with these ulcers. Finally, we are excited to add another significant new product into our line, now that our sales force is up and running with our successful launch of MEDIHONEY. This represents another step in the implementation of our strategic plan to drive shareholder value through the launch of novel, higher margin technologies,” Quilty continued.
MOBILITY1 is based on two patents that allow the compressed air to be driven while patients move about. This allows them to continue with their typical lifestyle. The device is equipped with a small compressor that can be used while patients are at rest.
About QualityStocks
QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 500,000+ subscribers that receive The Daily Stock Newsletters.
To sign up for “The QualityStocks Daily Newsletter” please visit http://www.qualitystocks.net/
Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
